• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    National Vision Appoints Caitlin Zulla to Board of Directors

    8/1/24 4:30:00 PM ET
    $EYE
    Ophthalmic Goods
    Health Care
    Get the next $EYE alert in real time by email

    Adds Healthcare and Financial Expertise to Board

    National Vision Holdings, Inc. (NASDAQ:EYE), one of the nation's largest optical retailers providing quality, affordable eye care and eyewear, announced today the appointment of Caitlin Zulla to its Board of Directors, effective immediately. Zulla will serve on the Board's Compensation Committee.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240801515969/en/

    (Photo: Business Wire)

    (Photo: Business Wire)

    Zulla brings an extensive healthcare background, with expertise in primary care and specialty care services. She currently serves as Chief Executive Officer of Optum Health East, part of UnitedHealth Group, where she is responsible for healthcare delivery for over 5.4 million patients across 10 states, leading more than 15,000 team members. Previously, Zulla held several executive positions at SCA Health, a specialist alignment organization and leader in the ambulatory surgery center industry, including Chief Executive Officer, Chief Financial Officer and Chief Administrative Officer. Zulla holds a Bachelor of Arts from Princeton University, a Master of Public Health and Health Management from Columbia University and a Master of Healthcare Delivery Science from Dartmouth College.

    "Caitlin has tremendous expertise across the healthcare value chain as well as a strong finance background that will be immediately additive to the National Vision Board," said Randy Peeler, Chairman of National Vision's Board of Directors. "Continuous refreshment is a core responsibility for our Board to support the Company's long-term goals and sustainable value creation."

    Zulla said, "High quality and affordable healthcare, including vision care, is essential to our communities. National Vision plays a critical role in enabling millions of people to receive their much-needed eye care and eyewear. I am excited to leverage my background and join the Board to help oversee National Vision's continued growth."

    Reade Fahs, Chief Executive Officer of National Vision, said, "Caitlin brings unique perspective at the intersection of patient care, physician partnerships and executive leadership. She has a keen understanding of our business and the customers and patients we serve and brings direct experience in advancing and promoting value-based care. I am looking forward to benefitting from her skillset as we continue to execute on our strategic initiatives."

    About National Vision Holdings, Inc.

    National Vision Holdings, Inc. (NASDAQ:EYE) is one of the largest optical retail companies in the United States with over 1,200 stores in 38 states and Puerto Rico. With a mission of helping people by making quality eye care and eyewear more affordable and accessible, the company operates four retail brands: America's Best, Eyeglass World, and Vista Opticals inside select Fred Meyer stores and on select military bases, and an e-commerce website DiscountContacts.com, offering a variety of products and services for customers' eye care needs. For more information, please visit www.nationalvision.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240801515969/en/

    Get the next $EYE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EYE

    DatePrice TargetRatingAnalyst
    7/30/2025$36.00Buy
    Roth Capital
    7/8/2025$30.00Equal Weight → Overweight
    Barclays
    5/9/2025$21.00Neutral → Buy
    Citigroup
    5/7/2025Underperform → Buy
    BofA Securities
    10/17/2023$25.00 → $16.00Buy → Neutral
    Goldman
    7/27/2023$28.00 → $22.00Buy → Neutral
    Citigroup
    7/27/2023$30.00 → $21.00Overweight → Equal Weight
    Wells Fargo
    5/2/2023Overweight → Equal Weight
    Barclays
    More analyst ratings

    $EYE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on National Vision with a new price target

    Roth Capital initiated coverage of National Vision with a rating of Buy and set a new price target of $36.00

    7/30/25 7:33:08 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision upgraded by Barclays with a new price target

    Barclays upgraded National Vision from Equal Weight to Overweight and set a new price target of $30.00

    7/8/25 8:23:14 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision upgraded by Citigroup with a new price target

    Citigroup upgraded National Vision from Neutral to Buy and set a new price target of $21.00

    5/9/25 8:39:42 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    $EYE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Peeler D Randolph bought $264,200 worth of shares (25,000 units at $10.57) (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    8/14/24 4:27:52 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Director Hepner Virginia A bought $10,365 worth of shares (1,000 units at $10.37), increasing direct ownership by 3% to 36,635 units (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    8/14/24 4:26:51 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Fahs L Reade bought $299,200 worth of shares (20,000 units at $14.96), increasing direct ownership by 3% to 633,097 units (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    5/14/24 8:01:46 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    $EYE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    America's Best Unveils Major Brand Transformation: VML Relaunches Eye Care Retailer's Identity with the Powerful Message "Every Eye Deserves Better"

    Brand's fresh, joyful new look designed to appeal to all Americans, conveying affordable access to high-quality eye care DULUTH, Ga., Aug. 19, 2025 /PRNewswire/ -- America's Best, a retail brand of National Vision Holdings, Inc. (NASDAQ:EYE), is excited to announce today a monumental visual brand transformation that promises to continue redefining accessible eye care across the nation. In collaboration with creative powerhouse VML, America's Best has embraced a bold renewal – unveiling a new logo, a new brand platform and a complete brand identity overhaul that will captivate consumers across all media touchpoints. Experience the full interactive Multichannel News Release here: https://www.

    8/19/25 9:00:00 AM ET
    $EYE
    $WPP
    Ophthalmic Goods
    Health Care
    Advertising
    Consumer Discretionary

    National Vision Holdings, Inc. Reports Second Quarter 2025 Financial Results

    Accelerated Initiatives Drive Comparable Store Sales Growth and Improved Profitability Raises Fiscal 2025 Outlook Second quarter 2025 highlights compared to second quarter 2024: Net revenue from continuing operations increased 7.7% to $486.4 million Comparable store sales growth of 6.5% and Adjusted Comparable Store Sales Growth of 5.9% represented the 10th consecutive quarter of positive growth Income from continuing operations of $8.7 million, Diluted EPS from continuing operations of $0.11 Adjusted Operating Income from continuing operations of $23.8 million, up 69.1%, with Adjusted Operating Margin improving to 4.9% from 3.1% Adjusted Diluted EPS from continuing operati

    8/6/25 6:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision, Inc. Unveils Bold New Brand Identity as Part of Strategic Transformation

    Brand refresh underscores National Vision's continued business evolution and unwavering commitment to accessible, high-quality eye care and eyewear DULUTH, Ga., Aug. 5, 2025 /PRNewswire/ -- National Vision Holdings, Inc. (NASDAQ:EYE), one of the largest optical retail companies in the United States, unveiled its new corporate brand identity, a major milestone in National Vision's transformation journey. The refreshed branding strengthens National Vision's position as a modern, agile and purpose-driven organization committed to helping people see their best to live their best. Experience the full interactive Multichannel News Release here: https://www.multivu.com/national-vision-holdings/934

    8/5/25 8:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    $EYE
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by National Vision Holdings Inc.

    SCHEDULE 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    8/13/25 4:00:04 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    SEC Form 10-Q filed by National Vision Holdings Inc.

    10-Q - National Vision Holdings, Inc. (0001710155) (Filer)

    8/7/25 8:33:06 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - National Vision Holdings, Inc. (0001710155) (Filer)

    8/6/25 6:07:10 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    $EYE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Executive Officer Wilkes Alexander

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    8/4/25 4:32:18 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    President, America's Best Banner Mark converted options into 11,728 shares and covered exercise/tax liability with 3,462 shares (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    7/9/25 4:21:56 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Director Zulla Caitlin was granted 10,870 units of Restricted Stock Units, increasing direct ownership by 99% to 21,880 units (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    6/23/25 4:40:50 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    $EYE
    Leadership Updates

    Live Leadership Updates

    View All

    National Vision, Inc. Unveils Bold New Brand Identity as Part of Strategic Transformation

    Brand refresh underscores National Vision's continued business evolution and unwavering commitment to accessible, high-quality eye care and eyewear DULUTH, Ga., Aug. 5, 2025 /PRNewswire/ -- National Vision Holdings, Inc. (NASDAQ:EYE), one of the largest optical retail companies in the United States, unveiled its new corporate brand identity, a major milestone in National Vision's transformation journey. The refreshed branding strengthens National Vision's position as a modern, agile and purpose-driven organization committed to helping people see their best to live their best. Experience the full interactive Multichannel News Release here: https://www.multivu.com/national-vision-holdings/934

    8/5/25 8:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Appoints Alex Wilkes as CEO

    Reade Fahs to Assume Executive Chairman Position Transition Effective August 1, 2025 National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced that its Board of Directors has appointed Alex Wilkes as the Company's next Chief Executive Officer, effective August 1, 2025, and he will join the Company's Board at that time. Mr. Wilkes succeeds Reade Fahs who will assume the role of Executive Chairman of the Board. Mr. Fahs will continue to work closely with Mr. Wilkes, ensuring a smooth transition. "National Vision has been on a journey of significant transformation for the past few years, and today I am pleased to announce the next chapter in that tran

    4/29/25 6:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Appoints Jim McGrann and Michael Nicholson to Board of Directors

    Enters into Cooperation Agreement with Engine Capital National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced the appointment of two new independent directors, Jim McGrann and Michael Nicholson to its Board of Directors (the "Board"), effective March 17, 2025. Mr. McGrann will serve on the Board's Compensation Committee and Mr. Nicholson will serve on the Board's Audit Committee and Nominating and Corporate Governance Committee. With the addition of Messrs. McGrann and Nicholson, the Board will expand from 9 to 11 members. The Board has also formed an Advisory Committee that will help oversee National Vision's ongoing transformation initiatives with

    3/17/25 4:05:00 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    $EYE
    Financials

    Live finance-specific insights

    View All

    National Vision Holdings, Inc. Reports Second Quarter 2025 Financial Results

    Accelerated Initiatives Drive Comparable Store Sales Growth and Improved Profitability Raises Fiscal 2025 Outlook Second quarter 2025 highlights compared to second quarter 2024: Net revenue from continuing operations increased 7.7% to $486.4 million Comparable store sales growth of 6.5% and Adjusted Comparable Store Sales Growth of 5.9% represented the 10th consecutive quarter of positive growth Income from continuing operations of $8.7 million, Diluted EPS from continuing operations of $0.11 Adjusted Operating Income from continuing operations of $23.8 million, up 69.1%, with Adjusted Operating Margin improving to 4.9% from 3.1% Adjusted Diluted EPS from continuing operati

    8/6/25 6:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call

    National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its second quarter 2025 financial results before the market opens on Wednesday, August 6, 2025, and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at https://ir.nationalvision.com/. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available shortly after the broadcast. About National Vision Holdings,

    7/23/25 8:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc. Reports First Quarter 2025 Financial Results

    Successful Execution of New Transformation Initiatives and Cost Reduction Actions Delivered Strong First Quarter First quarter 2025 highlights compared to Q1 2024: Net revenue from continuing operations of $510.3 million, an increase of 5.7% Comparable store sales growth of 4.1% and Adjusted Comparable Store Sales Growth of 5.5% represented the 9th consecutive quarter of positive growth Income from continuing operations of $14.2 million, Diluted EPS from continuing operations of $0.18 Adjusted Operating Income from continuing operations of $41.3 million Adjusted Diluted EPS from continuing operations of $0.34 Raises fiscal 2025 outlook National Vision Holdings, Inc. (NASDAQ:E

    5/7/25 6:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    $EYE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by National Vision Holdings Inc.

    SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    11/14/24 12:33:08 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13G/A filed by National Vision Holdings Inc.

    SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    11/12/24 4:45:48 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13G/A filed by National Vision Holdings Inc.

    SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    11/4/24 1:18:26 PM ET
    $EYE
    Ophthalmic Goods
    Health Care